Health In Tech (HIT) General Counsel awarded 5,000 restricted Class A shares

Rhea-AI Filing Summary

McStravock John reported acquisition or exercise transactions in this Form 4 filing.

Health In Tech, Inc. reported that General Counsel John McStravock received a grant of 5,000 restricted shares of Class A Common Stock as equity compensation. These shares were granted at no cash cost to him.

The restricted shares will vest in equal monthly installments over a twelve-month period starting on April 6, 2026, as long as he continues to serve with the company through each vesting date. After this grant, he holds 5,000 Class A shares directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider McStravock John

Role General Counsel

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	5,000	$0.00	--

Holdings After Transaction: Class A Common Stock — 5,000 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Restricted share grant: 5,000 shares Grant price per share: $0.0000 per share Shares held after grant: 5,000 shares +2 more

5 metrics

Restricted share grant 5,000 shares Class A Common Stock awarded to General Counsel

Grant price per share $0.0000 per share Reported value on equity award

Shares held after grant 5,000 shares Direct ownership following transaction

Vesting period 12 months Equal monthly vesting installments

Vesting start date April 6, 2026 Commencement of monthly vesting

Key Terms

restricted shares, Equity Incentive Plan, vest, Class A Common Stock, +1 more

5 terms

restricted shares financial

"Represents restricted shares of Class A Common Stock granted to the reporting person"

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

Equity Incentive Plan financial

"granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan"

An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

vest financial

"The restricted shares vest in equal monthly instalments over a twelve (12) month period"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

Class A Common Stock financial

"Represents restricted shares of Class A Common Stock granted to the reporting person"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

continued service financial

"subject to the reporting person's continued service with the registrant through each applicable vesting date"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McStravock John

(Last) (First) (Middle)

701 S. COLORADO AVE

SUITE 1

(Street)

STUART FLORIDA 34994

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Health In Tech, Inc. [ HIT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Counsel

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	04/10/2026		A		5,000(1)	A	$0.00	5,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The restricted shares vest in equal monthly instalments over a twelve (12) month period, commencing on April 6, 2026, subject to the reporting person's continued service with the registrant through each applicable vesting date.

	/s/ John P. McStravock	04/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Health In Tech (HIT) report for John McStravock?

Health In Tech reported that General Counsel John McStravock received a grant of 5,000 restricted Class A Common Stock shares. The award represents equity compensation, not an open-market share purchase, and was reported on a Form 4 insider filing.

How many Health In Tech (HIT) shares did John McStravock acquire?

John McStravock was granted 5,000 restricted shares of Health In Tech Class A Common Stock. These were awarded at a stated price of $0.0000 per share, reflecting a compensation grant rather than a market transaction involving cash consideration.

When do John McStravock’s restricted HIT shares start vesting?

The restricted shares begin vesting on April 6, 2026. Vesting occurs in equal monthly installments over twelve months, and each installment requires his continued service with Health In Tech through the applicable vesting date to be earned.

What plan governs John McStravock’s restricted share grant at Health In Tech (HIT)?

The restricted Class A Common Stock granted to John McStravock was issued under the Health In Tech Equity Incentive Plan. This plan governs the terms of equity awards, including vesting conditions tied to ongoing service with the company.

How many Health In Tech (HIT) shares does John McStravock hold after this transaction?

Following the reported grant, John McStravock directly holds 5,000 shares of Health In Tech Class A Common Stock. These shares are subject to the described vesting schedule, so they are restricted until the applicable vesting dates are satisfied.

Is John McStravock’s Form 4 transaction a market purchase of HIT stock?

No, the Form 4 shows a grant of restricted shares, not a market purchase. The 5,000 Class A shares were awarded as compensation with a reported price of $0.0000 per share, rather than bought on the open market.